Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Mov Disord. 2023 May 2;38(9):1757–1759. doi: 10.1002/mds.29428
Zainab Zaman Employed by Boston Children’s Hospital.
Nadine Straka Employed by Boston Children’s Hospital.
Anna L. Pinto Employed by Boston Children’s Hospital.
Rasha Srouji Employed by Boston Children’s Hospital.
Amy Tam Employed by Boston Children’s Hospital.
Scellig Stone Employed by Boston Children’s Hospital.
Monica Kleinman Employed by Boston Children’s Hospital.
Weston T. Northam Employed by Boston Children’s Hospital.
Darius Ebrahimi-Fakhari Employed by Boston Children’s Hospital. Research grants: NIH/NINDS, CureAP4 Foundation, CureSPG50 Foundation, Spastic Paraplegia Foundation, Tom Wahlig Foundation, Manton Center for Orphan Disease Research, BCH Office of Faculty Development, BCH Translational Research Program. Joint research agreement: Astellas Pharmaceuticals Inc.. Royalties: Cambridge University Press. Speaker honoraria: Movement Disorders Society. Scientific advisory board (unpaid): CureAP4 Foundation, The Maddie Foundation, SPG69/Warburg Micro Research Foundation, Genetic Cures for Kids Inc., Lilly and Blair Foundation, The SPG15 Research Foundation. Local advisory committees (unpaid): BCH Gene Therapy Scientific Review Committee. International advisory committees (unpaid): Movement Disorders Society - Taskforce on the Nomenclature of Genetic Movement Disorders, Taskforce on Pediatric Movement Disorders